Visualitzant per matèria "Medicaments -- Administració"
Ara mostrant els elements 1-4 de 4
-
Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions
(Scientific reports, 2021, 11, 883, 2021-01)Drug-related problems (DRP) cause preventable negative health outcomes, especially during hospital admissions. The aim of our study was to examine the prevalence and characteristics of DRP in regular ... -
Effects of a multifaceted intervention in psychogeriatric patients: one-year prospective study
(European Journal of Hospital Pharmacy, 2020, 27:226-231, 2020-06)Objectives The aetiology of behavioural and psychological symptoms (BPSD) could be related to inadequate treatment in patients with dementia. The aim of this study was to determine how a multifaceted ... -
Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: preclinical and real-life clinical data
(The Breast, 2022, 62: 1-9, 2022-01)After the expiration of trastuzumab data exclusivity, biosimilar drugs were approved by regulatory agencies; among them, CT-P6 which was approved for the treatment of HER2-positive early- and advanced-breast ... -
Safety of nanoparticle therapies during pregnancy: A systematic review and meta-analysis
(Journal of Controlled Release, 2025, 382: 113655, 2025-06)The exclusion of pregnant women from clinical trials has led to insufficient safety data for many treatments, making it necessary to evaluate their potential benefits and risks during preclinical stages. ...